Ftse Mib
34.375,92
-0,59%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
64.757,05
-0,15%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lixte Biotechnology Holdings Inc (LIXT) Lixte Biotechnology Holdings Inc (LIXT) Notizie

LIXT

Lixte Biotechnology (LIXT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LIXT
DataOraFonteTitoloSimboloCompagnia
01/12/202018:30GlobeNewswire Inc.Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to NasdaqNASDAQ:LIXTLixte Biotechnology Holdings Inc
30/11/202021:52Business WireWestPark Capital Announces Closing of $5,700,000 Follow-On Offering & NASDAQ Up-listing of Lixte Biotechnology Holdings, Inc....NASDAQ:LIXTLixte Biotechnology Holdings Inc
27/11/202023:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:LIXTLixte Biotechnology Holdings Inc
27/11/202022:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LIXTLixte Biotechnology Holdings Inc
25/11/202014:30GlobeNewswire Inc.Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Re...NASDAQ:LIXTLixte Biotechnology Holdings Inc
02/07/200915:00PR Newswire (US)Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal ModelsNASDAQ:LIXT
20/10/200815:20PR Newswire (US)Lixte Biotechnology Holdings Announces New Appointment to Board of DirectorsNASDAQ:LIXT
19/08/200814:15PR Newswire (US)Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by NNASDAQ:LIXT
12/08/200816:18PR Newswire (US)Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential TreatmentNASDAQ:LIXT
08/08/200815:15PR Newswire (US)Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have PositiNASDAQ:LIXT
25/06/200817:36PR Newswire (US)Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National InstituNASDAQ:LIXT
23/04/200816:00PR Newswire (US)Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the AnnNASDAQ:LIXT
26/02/200821:29PR Newswire (US)Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending ProprNASDAQ:LIXT
18/12/200720:47PR Newswire (US)Lixte Biotechnology Holdings, Inc. Announces Completion of Private PlacementNASDAQ:LIXT
29/11/200714:05PR Newswire (US)Lixte Biotechnology Holdings Announces New Appointment To Board Of DirectorsNASDAQ:LIXT
24/09/200714:00PR Newswire (US)Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXTNASDAQ:LIXT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LIXT

La tua Cronologia

BIT
P1OYI5
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network